Viewing Study NCT00082602


Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2026-03-09 @ 9:19 AM
Study NCT ID: NCT00082602
Status: COMPLETED
Last Update Posted: 2011-05-20
First Post: 2004-05-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR004699
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View